---
figid: PMC9666118__po-6-e2200246-g002
pmcid: PMC9666118
image_filename: po-6-e2200246-g002.jpg
figure_link: /pmc/articles/PMC9666118/figure/fig1/
number: FIG 1
figure_title: ''
caption: Step-by-step approach for analyzing the number of patients with advanced
  non–small-cell lung cancer lost at each step of the precision oncology pathway.
  CNB, core-needle biopsies; ddPCR, droplet digital polymerase chain reaction; FISH,
  fluorescence in situ hybridization; FNA, fine-needle aspirates; IHC, immunohistochemistry;
  IO, immuno-oncology; aNSCLS, advanced non-small-cell lung cancer; NGS, next-generation
  sequencing; PD-L1, programmed death-ligand 1; RT-PCR, reverse transcriptase polymerase
  chain reaction; TKI, tyrosine kinase inhibitor.
article_title: Impact of Clinical Practice Gaps on the Implementation of Personalized
  Medicine in Advanced Non–Small-Cell Lung Cancer.
citation: Helen Sadik, et al. JCO Precis Oncol. 2022;6:e2200246.
year: '2022'

doi: 10.1200/PO.22.00246
journal_title: JCO Precision Oncology
journal_nlm_ta: JCO Precis Oncol
publisher_name: Wolters Kluwer Health

keywords:
---
